Video

Dr. Ghodoussipour on Ongoing Trials in Non–Muscle Invasive Bladder Cancer

Saum Ghodoussipour, MD, discusses ongoing trials in non–muscle invasive bladder cancer.

Saum Ghodoussipour, MD, urologic oncologist, director, Bladder and Urothelial Cancer Program, Rutgers Cancer Institute of New Jersey, assistant professor of surgery, Rutgers Robert Wood Johnson Medical School, attending, Robert Wood Johnson University Hospital, discusses ongoing trials in non–muscle invasive bladder cancer (NMIBC).

Several interesting studies are taking place currently in NMIBC, which is how most patients with bladder cancer present, Ghodoussipour says. The standard of care currently is intravesical therapy with Bacillus Calmette-Guérin (BCG), the vaccine for tuberculosis, Ghodoussipour adds. The therapy stimulates a local immune response in this patient population; however, almost half of patients do not derive a response resulting in the need for additional invasive treatments, Ghodoussipour explains.

Clinicians are studying BCG in combination with the checkpoint inhibitor pembrolizumab (Keytruda), with the goal of improving treatment after prior failure with BCG, Ghodoussipour continues. Moreover, clinicians are attempting to give BCG and pembrolizumab in the frontline setting for patients with treatment-naïve NMIBC to see whether it will improve outcomes for patients, Ghodoussipour concludes.

Related Videos
Yair Lotan, MD, UT Southwestern Medical Center
Alan Tan, MD, Vanderbilt-Ingram Cancer Center
Alex Herrera, MD
Roy S. Herbst, MD, PhD
Sheldon M. Feldman, MD
Laura J. Chambers, DO
Thomas Westbrook, MD
Massimo Cristofanilli, MD, attending physician, NewYork-Presbyterian Hospital; professor, medicine, Weill Cornell Medical College, Cornell University
Fred Saad, CQ, MD, FRCS, FCAHS, director, Prostate Cancer Research, Montreal Cancer Institute, Centre Hospitalier de l’Université de Montréal; full professor, Department of Surgery, Université de Montréal; uro-oncologist, Urology Department, University of Montreal Health Center
Ajay K. Nooka, MD, MPH, FACP